TNYA – tenaya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting
Augustine secures $85m to advance Charcot-Marie-Tooth candidate [Yahoo! Finance]
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
Tenaya Therapeutics, Inc. (TNYA) Stock [Seeking Alpha]
Form EFFECT Tenaya Therapeutics,
Form 8-K Tenaya Therapeutics, For: Mar 27
Form S-3 Tenaya Therapeutics,
Form 4 Tenaya Therapeutics, For: Mar 10 Filed by: Higa Tomohiro
Form 4 Tenaya Therapeutics, For: Mar 10 Filed by: Tingley Whittemore
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.